{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Régions pseudo-autosomiques : Questions médicales les plus fréquentes",
"headline": "Régions pseudo-autosomiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Régions pseudo-autosomiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-05",
"dateModified": "2025-03-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Régions pseudo-autosomiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Locus génétiques",
"url": "https://questionsmedicales.fr/mesh/D056426",
"about": {
"@type": "MedicalCondition",
"name": "Locus génétiques",
"code": {
"@type": "MedicalCode",
"code": "D056426",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.380"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Régions pseudo-autosomiques",
"alternateName": "Pseudoautosomal Regions",
"code": {
"@type": "MedicalCode",
"code": "D000071439",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Maki Fukami",
"url": "https://questionsmedicales.fr/author/Maki%20Fukami",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Erina Suzuki",
"url": "https://questionsmedicales.fr/author/Erina%20Suzuki",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Atsushi Hattori",
"url": "https://questionsmedicales.fr/author/Atsushi%20Hattori",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Emma E Wolters",
"url": "https://questionsmedicales.fr/author/Emma%20E%20Wolters",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands. ee.wolters@amsterdamumc.nl."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Service Demand for and Awareness of a Primary Healthcare Pilot Project for People With Disabilities.",
"datePublished": "2022-08-01",
"url": "https://questionsmedicales.fr/article/35916049",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3346/jkms.2022.37.e241"
}
},
{
"@type": "ScholarlyArticle",
"name": "[The KomMent study: a pilot project on structured interprofessional communication in uro-oncology].",
"datePublished": "2022-10-07",
"url": "https://questionsmedicales.fr/article/36205744",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00120-022-01945-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Psychiatric-Psychotherapeutic Care in Crisis: Results of the LeiP#Netz Pilot Project].",
"datePublished": "2022-11-25",
"url": "https://questionsmedicales.fr/article/36427493",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-1902-6326"
}
},
{
"@type": "ScholarlyArticle",
"name": "Adaptation of Screening Tools for Social Determinants of Health in Pregnancy: A Pilot Project.",
"datePublished": "2023-06-14",
"url": "https://questionsmedicales.fr/article/37316688",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10995-023-03732-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Colorectal Cancer Screening Pilot Project in Tehran-Iran, a Feasibility Study.",
"datePublished": "2023-03-01",
"url": "https://questionsmedicales.fr/article/37543936",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.34172/aim.2023.22"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Structures génétiques",
"item": "https://questionsmedicales.fr/mesh/D040342"
},
{
"@type": "ListItem",
"position": 4,
"name": "Génome",
"item": "https://questionsmedicales.fr/mesh/D016678"
},
{
"@type": "ListItem",
"position": 5,
"name": "Composants de génome",
"item": "https://questionsmedicales.fr/mesh/D040481"
},
{
"@type": "ListItem",
"position": 6,
"name": "Locus génétiques",
"item": "https://questionsmedicales.fr/mesh/D056426"
},
{
"@type": "ListItem",
"position": 7,
"name": "Régions pseudo-autosomiques",
"item": "https://questionsmedicales.fr/mesh/D000071439"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Régions pseudo-autosomiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Régions pseudo-autosomiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Régions pseudo-autosomiques",
"description": "Comment diagnostiquer une anomalie des PAR ?\nQuels tests sont utilisés pour évaluer les PAR ?\nLes PAR peuvent-ils être détectés par échographie ?\nQuels signes cliniques indiquent une anomalie des PAR ?\nLes tests de dépistage sont-ils recommandés pour les PAR ?",
"url": "https://questionsmedicales.fr/mesh/D000071439?mesh_terms=Pilot+Projects&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Régions pseudo-autosomiques",
"description": "Quels symptômes sont associés aux anomalies des PAR ?\nLes anomalies des PAR affectent-elles la croissance ?\nY a-t-il des symptômes psychologiques liés aux anomalies des PAR ?\nLes anomalies des PAR peuvent-elles causer des douleurs ?\nLes anomalies des PAR sont-elles visibles à la naissance ?",
"url": "https://questionsmedicales.fr/mesh/D000071439?mesh_terms=Pilot+Projects&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Régions pseudo-autosomiques",
"description": "Comment prévenir les anomalies des PAR ?\nLes vaccinations peuvent-elles prévenir les anomalies des PAR ?\nLe mode de vie influence-t-il les anomalies des PAR ?\nLes tests génétiques préconceptionnels sont-ils utiles ?\nLes conseils nutritionnels aident-ils à prévenir les anomalies ?",
"url": "https://questionsmedicales.fr/mesh/D000071439?mesh_terms=Pilot+Projects&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Régions pseudo-autosomiques",
"description": "Quels traitements existent pour les anomalies des PAR ?\nLes traitements sont-ils personnalisés pour chaque patient ?\nLes traitements médicaux sont-ils efficaces pour les anomalies des PAR ?\nY a-t-il des traitements préventifs pour les anomalies des PAR ?\nLes thérapies psychologiques sont-elles recommandées ?",
"url": "https://questionsmedicales.fr/mesh/D000071439?mesh_terms=Pilot+Projects&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Régions pseudo-autosomiques",
"description": "Quelles complications peuvent survenir avec les anomalies des PAR ?\nLes anomalies des PAR augmentent-elles le risque de cancer ?\nLes complications psychologiques sont-elles fréquentes ?\nLes anomalies des PAR peuvent-elles affecter la grossesse ?\nY a-t-il des complications à long terme liées aux anomalies des PAR ?",
"url": "https://questionsmedicales.fr/mesh/D000071439?mesh_terms=Pilot+Projects&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Régions pseudo-autosomiques",
"description": "Quels sont les facteurs de risque pour les anomalies des PAR ?\nLes facteurs environnementaux influencent-ils les anomalies des PAR ?\nLes maladies génétiques augmentent-elles le risque d'anomalies des PAR ?\nLe mode de vie peut-il affecter le risque d'anomalies des PAR ?\nLes traitements médicaux antérieurs influencent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D000071439?mesh_terms=Pilot+Projects&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie des PAR ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par analyse génétique, incluant le caryotype et le séquençage."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les PAR ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent le séquençage de l'ADN et l'hybridation in situ fluorescente."
}
},
{
"@type": "Question",
"name": "Les PAR peuvent-ils être détectés par échographie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, l'échographie ne peut pas détecter les anomalies des PAR, seule l'analyse génétique le peut."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une anomalie des PAR ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes peuvent inclure des troubles de la fertilité ou des anomalies de développement sexuel."
}
},
{
"@type": "Question",
"name": "Les tests de dépistage sont-ils recommandés pour les PAR ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage est recommandé pour les couples à risque d'anomalies génétiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés aux anomalies des PAR ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des dysfonctionnements hormonaux et des malformations congénitales."
}
},
{
"@type": "Question",
"name": "Les anomalies des PAR affectent-elles la croissance ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner des retards de croissance et des problèmes de développement."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes psychologiques liés aux anomalies des PAR ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles psychologiques peuvent survenir, notamment l'anxiété et la dépression."
}
},
{
"@type": "Question",
"name": "Les anomalies des PAR peuvent-elles causer des douleurs ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des douleurs liées à des malformations ou des déséquilibres hormonaux."
}
},
{
"@type": "Question",
"name": "Les anomalies des PAR sont-elles visibles à la naissance ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines anomalies peuvent être visibles à la naissance, mais d'autres se manifestent plus tard."
}
},
{
"@type": "Question",
"name": "Comment prévenir les anomalies des PAR ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par le conseil génétique et le dépistage prénatal pour les couples à risque."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles prévenir les anomalies des PAR ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccinations ne préviennent pas les anomalies chromosomiques comme celles des PAR."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il les anomalies des PAR ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain peut réduire certains risques, mais ne prévient pas toutes les anomalies."
}
},
{
"@type": "Question",
"name": "Les tests génétiques préconceptionnels sont-ils utiles ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent identifier des risques d'anomalies génétiques chez les futurs parents."
}
},
{
"@type": "Question",
"name": "Les conseils nutritionnels aident-ils à prévenir les anomalies ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne nutrition peut soutenir la santé reproductive, mais ne prévient pas directement les anomalies."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les anomalies des PAR ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements peuvent inclure des thérapies hormonales et des interventions chirurgicales."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés pour chaque patient ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont souvent adaptés en fonction des symptômes et des besoins individuels."
}
},
{
"@type": "Question",
"name": "Les traitements médicaux sont-ils efficaces pour les anomalies des PAR ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité varie selon le type d'anomalie et la réponse individuelle au traitement."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements préventifs pour les anomalies des PAR ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de traitements préventifs spécifiques pour les anomalies des PAR."
}
},
{
"@type": "Question",
"name": "Les thérapies psychologiques sont-elles recommandées ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les thérapies psychologiques peuvent aider à gérer les impacts émotionnels des anomalies."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les anomalies des PAR ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des problèmes de fertilité, des malformations et des troubles endocriniens."
}
},
{
"@type": "Question",
"name": "Les anomalies des PAR augmentent-elles le risque de cancer ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien, mais des recherches supplémentaires sont nécessaires."
}
},
{
"@type": "Question",
"name": "Les complications psychologiques sont-elles fréquentes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications psychologiques comme l'anxiété et la dépression sont courantes."
}
},
{
"@type": "Question",
"name": "Les anomalies des PAR peuvent-elles affecter la grossesse ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des complications pendant la grossesse, comme des fausses couches."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications à long terme liées aux anomalies des PAR ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications à long terme peuvent inclure des problèmes de santé chroniques et des troubles de développement."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les anomalies des PAR ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge parental avancé et des antécédents familiaux d'anomalies génétiques."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux influencent-ils les anomalies des PAR ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certaines substances chimiques peut augmenter le risque d'anomalies."
}
},
{
"@type": "Question",
"name": "Les maladies génétiques augmentent-elles le risque d'anomalies des PAR ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies génétiques peuvent être associées à un risque accru d'anomalies des PAR."
}
},
{
"@type": "Question",
"name": "Le mode de vie peut-il affecter le risque d'anomalies des PAR ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie malsain, comme le tabagisme, peut augmenter le risque d'anomalies génétiques."
}
},
{
"@type": "Question",
"name": "Les traitements médicaux antérieurs influencent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains traitements médicaux, comme la chimiothérapie, peuvent affecter le risque d'anomalies."
}
}
]
}
]
}
This study investigated the demand for and awareness of a primary healthcare pilot project for people with disabilities; it also sought to identify relevant determinants for demand and awareness using...
This study is a secondary analysis of data from the population-based survey conducted in Gyeonggi Regional Health & Medical Center for People with Disabilities. The data was designed with quota ra...
Awareness of the service (12.1%) was remarkably low, while the demand (80.5%) was high. The gap between respondents who needed the service but were unaware of it differed according to age, education, ...
Chronic disease and an unmet need for medical care were key determinants of service demand, while the severity of disability was not. Thus, there is a need to review the initiative that defines servic...
Communication and interprofessional collaboration with patients diagnosed with cancer is challenging. Structured communication training has not yet been integrated into postgraduate medical education....
A needs assessment was conducted using focus groups and individual interviews. Learning objectives were aligned with (inter)national learning objective catalogs. The ICT was developed using the six-st...
Physician participation rates in the workshops were 83.0% and nursing participation rates were 58.3%. Utilization of the workplace-based training was 97%. The physicians evaluated the ICT very positiv...
The implementation of an ICT with 80 teaching units is successfully feasible in a urological clinic and leads to a sustainable improvement of the communication culture, among other things through ment...
Analysis of psychiatric-psychotherapeutic crisis services in the Leipzig Psychiatry Network (LeiP#netz), assigning the services to the functional areas of the FBM according to Steinhart and Wienberg....
A standardized survey of crisis care was conducted using the functions "complex outpatient treatment", "access to acute psychotherapy in crisis", and "24 h complex, intensive treatment" by means of fa...
A total of 31 measures were recorded for the three functions. All crisis care services were highly utilized; in up to one-third of cases, no services could be provided when demand was requested. Servi...
Crisis care services for severely mentally ill people are available in various constellations in the study region. Low-threshold 24/7 crisis services need to be expanded....
Social determinants of health (SDOH) and stress during pregnancy may contribute to adverse pregnancy outcomes. The objective of this in the field pilot project was to develop a comprehensive screening...
Pregnant patients accessing prenatal care at a single site of an urban Federally Qualified Health Center were recruited during prenatal visits to complete a Social Determinants of Health in Pregnancy ...
Between April 2018 and March 2019, 135 pregnant participants completed SIPT. Ninety-one percent of patients scored positive on at least one screener, 54% to three or more screeners....
Despite guidelines to screen for SDOH during pregnancy there is no universal tool. Our pilot project demonstrated the concurrent use of adapted screening tools where participants reported at least one...
Colorectal cancer (CRC) is the third most common cancer in Iran, where there is no organised CRC-screening programme. This study aimed to evaluate feasibility of CRC screening using a qualitative feca...
In this feasibility study, 7039 individuals aged 50-75 years were invited by community health workers (CHWs) in southern Tehran and its suburban districts between April 2018 and November 2019. The CHW...
Acceptance rate at initial invitation was 71.7%. From 4974 average-risk adults (1600 males and 3374 females) who were offered FIT, 96.8% (n=4813) provided valid samples, of whom 471 (9.8%) tested posi...
Our results partially support the feasibility of scaling up organized CRC-screening through the existing healthcare system in Iran; it remains to be discussed carefully to ensure the capacity of healt...
Evidence synthesis organisations are trying to meet commissioners' needs for rapid responses to their evidence synthesis commissions. In this project we piloted an intensive process, working to comple...
In a pre-planning phase, an intensive work group was established, and two commissions were selected for this pilot project. The evidence synthesis process was divided into two phases: planning and int...
During the planning phase, teams identified significant uncertainties regarding scopes, research questions, and inclusion criteria. To address this, they engaged with commissioners earlier than origin...
Overall, the intensive process fostered focus and productivity, allowing teams to manage short-term deliverables effectively. The researchers preferred working intensively with one evidence synthesis ...
Families with one parent suffering from cancer are exposed to extraordinary emotional and organizational burdens, affecting underaged children. To help coordinated access to social and logistic suppor...
A cross-sectional observational study was conducted using a mixed-method approach. Semi-structured written expert surveys (n=10) and secondary analysis of routine data of the care model (n=171 familie...
Quantitative secondary analysis: The participating families had 1-7 children (median (m) 2, range (s) 6). In 66% of the cases, the mother was affected by cancer, in 20% the diseased parent was in a si...
The data collected indicate that in families, matching the German average in their socio-demographic characteristics, a great need for organizational support develops as soon as one parent becomes sic...
We initiate the Westlake BioBank for Chinese (WBBC) pilot project with 4,535 whole-genome sequencing (WGS) individuals and 5,841 high-density genotyping individuals, and identify 81.5 million SNPs and...
To report a pilot project of expert nurses for outpatient parenteral antimicrobial treatment (OPAT) follow-up....
Three nurses with specific training on antibiotics started a state-funded programme including: i) consultations for OPAT follow-up; ii) hotline for satellite hospitals; iii) peer training. Patients' d...
From December 2020 to December 2021, 118 patients (median age 66.5 years [52-75], male-to-female ratio 2.5) were enrolled, for a total of 621 consultations. Patients were mostly on OPAT for bone and j...
Nurses may be important actors for OPAT follow-up....
The Fellowship Council (FC) is transitioning to a competency-based medical education (CBME) model, including the introduction of Entrustable Professional Activities (EPAs) for training and assessment ...
The FC coordinated the development of EPAs in collaboration with the sponsoring societies for Advanced GI/MIS, Bariatrics, Foregut, Endoscopy and Hepatopancreaticobiliary (HPB) fellowships encompassin...
The 15 participating programs included 18 fellows and 106 faculty. A total of 655 assessments were initiated with 429 (65%) completed. The average (SD) number of EPAs completed for each fellow was 24(...
A competency-based assessment framework was developed by the FC and piloted in several programs. Participation was variable and required ongoing strategies to address barriers. The pilot project has p...